LENSAR stock highlights 18 percent Q2 revenue growth

Published on 10/07/2026 at 00:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

LENSAR stock posted USD 16.5 million in Q2 revenue on August 13, 2026, up 18 percent year over year. Recurring revenue reached USD 13.7 million and 83 percent of sales.

LNSR, US52634L1089, Illustration mit AI erstellt.

LENSAR (ISIN US52634L1089) reported USD 16.5 million in second-quarter 2026 revenue, an 18 percent increase from the prior-year period, according to The Globe and Mail on August 13, 2026. The result gives the cataract-surgery technology company a measurable operating base as it rebuilds commercial activity after returning to independent operations.

Q2 revenue rose 18 percent

Recurring revenue increased 20 percent year over year to USD 13.7 million and represented 83 percent of quarterly revenue, the earnings transcript reported. Procedure revenue climbed 23 percent to USD 10.2 million, while procedure volume reached 58,682, up 13 percent from the second quarter of 2025.

The operating mix is important because recurring revenue provides a larger contribution from the installed base after systems are placed. LENSAR ended the quarter with 215 ALLY systems installed, a 30 percent year-over-year increase, and a total global installed base of 445 systems, up 9 percent, according to The Globe and Mail.

Analysts weigh earnings improvement

LENSAR also exceeded the quarterly earnings comparison cited by MarketBeat on October 3, 2026. Adjusted earnings were USD 0.10 per share against a consensus estimate of a USD 0.16 loss, while revenue of USD 16.50 million exceeded the USD 14.65 million estimate.

MarketBeat listed two Buy ratings and one Sell rating, producing a Hold consensus with an average price target of USD 11.33 on October 3, 2026. The same report said Wall Street Zen cut its rating from Buy to Hold, adding a more cautious counterpoint to the quarter's growth figures.

Market value stood at USD 82.3 million

LNSR had a market capitalization of USD 82.3 million and trading volume of 33,926 shares on October 6, 2026. The stock's 52-week range was USD 4.95 to USD 12.94, giving investors a market-value frame for the company's Q2 operating progress.